618 related articles for article (PubMed ID: 8663871)
1. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
2. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.
Nightingale SD; Cameron DW; Gordin FM; Sullam PM; Cohn DL; Chaisson RE; Eron LJ; Sparti PD; Bihari B; Kaufman DL
N Engl J Med; 1993 Sep; 329(12):828-33. PubMed ID: 8179648
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Dautzenberg B; Saint Marc T; Meyohas MC; Eliaszewitch M; Haniez F; Rogues AM; De Wit S; Cotte L; Chauvin JP; Grosset J
Arch Intern Med; 1993 Feb; 153(3):368-72. PubMed ID: 8427539
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
10. The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS.
Mertl SL
Pharmacotherapy; 1996; 16(3):393-400. PubMed ID: 8726597
[TBL] [Abstract][Full Text] [Related]
11. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
Wright J
Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
[TBL] [Abstract][Full Text] [Related]
12. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.
Spector SA; McKinley GF; Lalezari JP; Samo T; Andruczk R; Follansbee S; Sparti PD; Havlir DV; Simpson G; Buhles W; Wong R; Stempien M
N Engl J Med; 1996 Jun; 334(23):1491-7. PubMed ID: 8618603
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
14. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
[TBL] [Abstract][Full Text] [Related]
16. Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.
Horsburgh CR; Gettings J; Alexander LN; Lennox JL
Clin Infect Dis; 2001 Dec; 33(11):1938-43. PubMed ID: 11692307
[TBL] [Abstract][Full Text] [Related]
17. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Craft JC; Notario GF; Grosset JH; Heifets LB
Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical manifestations of disseminated Mycobacterium avium complex infection in South Africans with acquired immunodeficiency syndrome.
Pettipher CA; Karstaedt AS; Hopley M
Clin Infect Dis; 2001 Dec; 33(12):2068-71. PubMed ID: 11698989
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Shafran SD
Clin Infect Dis; 1998 Oct; 27(4):813-5. PubMed ID: 9798038
[No Abstract] [Full Text] [Related]
20. Therapeutic options for the management and prevention of Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome.
Tartaglione TA
Pharmacotherapy; 1996; 16(2):171-82. PubMed ID: 8820462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
